Modelling cost-effectiveness of biologic treatments based on disease activity scores for the management of rheumatoid arthritis in Spain.
about
Cost-effectiveness modelling of sequential biologic strategies for the treatment of moderate to severe rheumatoid arthritis in Finland.Investigating the value of abatacept in the treatment of rheumatoid arthritis: a systematic review of cost-effectiveness studies.Administration costs of intravenous biologic drugs for rheumatoid arthritis.Cost Effectiveness of TNF-α Inhibitors in Rheumatoid Arthritis.Cost-effectiveness of abatacept for moderate-to-severe rheumatoid arthritis.Including adverse drug events in economic evaluations of anti-tumour necrosis factor-α drugs for adult rheumatoid arthritis: a systematic review of economic decision analytic models.How to select the right cost-effectiveness model? : A systematic review and stepwise approach for selecting a transferable health economic evaluation model for rheumatoid arthritis.Clinical and economic analysis of outcomes of dose tapering or withdrawal of tumor necrosis factor-α inhibitors upon achieving stable disease activity in rheumatoid arthritis patients.Modelling outcomes of complex treatment strategies following a clinical guideline for treatment decisions in patients with rheumatoid arthritis.Cost-utility analysis of tocilizumab monotherapy in first line versus standard of care for the treatment of rheumatoid arthritis in Greece.
P2860
Q35952231-EF599019-5D86-4E5E-A87A-80CC949AC253Q36931485-291127C8-F182-497D-9666-5DE1AC03D2D6Q37301258-C655690C-C9E1-4403-90F5-9875B86F0FEBQ37353329-0872DA0A-DB51-4009-B663-5F49011F1A8AQ38170177-31809A61-46B7-4197-869B-DC179BA2801DQ38171360-0704F23A-66B7-4884-8CF7-DF35C83B5E43Q38185992-C4392E3C-3330-4E9D-AD0A-F38FF63E1806Q38641431-7A257C64-3D43-43BA-A10B-C3A11D2E970BQ39168790-5A5F21B5-0B9C-43DD-A7AC-5AF36FAE7ECBQ41187128-75D7A863-2A26-492C-B069-B157BC6BE30D
P2860
Modelling cost-effectiveness of biologic treatments based on disease activity scores for the management of rheumatoid arthritis in Spain.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Modelling cost-effectiveness o ...... rheumatoid arthritis in Spain.
@ast
Modelling cost-effectiveness o ...... rheumatoid arthritis in Spain.
@en
type
label
Modelling cost-effectiveness o ...... rheumatoid arthritis in Spain.
@ast
Modelling cost-effectiveness o ...... rheumatoid arthritis in Spain.
@en
prefLabel
Modelling cost-effectiveness o ...... rheumatoid arthritis in Spain.
@ast
Modelling cost-effectiveness o ...... rheumatoid arthritis in Spain.
@en
P2093
P2860
P356
P1476
Modelling cost-effectiveness o ...... rheumatoid arthritis in Spain.
@en
P2093
Antonio Ramirez-Arellano
Ariel Beresniak
Danielle Dupont
Jose Francisco Garcia-Llorente
Rafael Ariza-Ariza
P2860
P304
P356
10.4061/2011/727634
P577
2011-06-28T00:00:00Z